Glacial Rx

R2 Technologies, Inc. is the world leader in CryoAesthetic™ medical devices. In 2014, Pansend Life Sciences, LLC and Blossom Innovations, LLC founded R2 Technologies and acquired exclusive intellectual property from Massachusetts General Hospital. In 2019, R2 introduced East China Medicine Co., Ltd. as a strategic partner. By closely collaborating with these partners, as well as the brand’s scientific founders and world-renowned aesthetic medicine experts Dr. Rox Anderson, Dr. Dieter Manstein, and Dr. Henry Chan, R2 focuses on the development, engineering, clinical research, and commercialization of breakthrough technologies for aesthetic providers and consumers.